PR Newswire
ISTANBUL, March 8, 2019
ISTANBUL, March 8, 2019 /PRNewswire/ -- MLP Sağlık Hizmetleri A.Ş. ("MLP Care") (BIST: MPARK), the leading private healthcare service provider in Turkey, today announces its financial results for the full year ended December 31, 2018.
(TL millon) | 2018 | 2017 | Change | Q4 2018 | Q4 2017 ARIVA.DE Börsen-GeflüsterWerbung Weiter aufwärts?
Morgan Stanley
Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie hier: ME619Q,. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Kurse | Change | ||||||||||
Revenue | 3,132 | 2,576 | 21.6% | 880 | 703 | 25.3% | ||||||||||
Comparable1 Revenue | 3,045 | 2,576 | 18.2% | 840 | 703 | 19.5% | ||||||||||
| | | | | | | ||||||||||
Adj. EBITDA2 | 505 | 409 | 23.5% | 152 | 126 | 20.3% | ||||||||||
Adj. Margin (%) | 16.1% | 15.9% | 25bps | 17.3% | 18.0% | (71bps) | ||||||||||
Comparable1 Adj. EBITDA | 530 | 409 | 29.7% | 155 | 126 | 22.9% | ||||||||||
Adj. Margin (%) | 17.4% | 15.9% | 155bps | 18.5% | 18.0% | 51bps | ||||||||||
Adj. EBITDAR2 | 748 | 598 | 25.1% | 215 | 176 | 22.2% | ||||||||||
Adj. Margin (%) | 23.9% | 23.2% | 68bps | 24.4% | 25.0% | (62bps) | ||||||||||
| | | | | | | ||||||||||
Net Profit/(Loss) | (104) | (133) | (21.9%) | 39 | (60) | (165.7%) | ||||||||||
Net Profit/(Loss) Normalized for FX | 142 | 35 | 300.1% | (1) | 21 | (102.5%) |
1 Excluding the contribution from hospitals opened in 2018
2 Based on Reported EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization) /EBITDAR (Earnings Before Interest, Taxes, Depreciation, Amortization, Rent Expenses) adjusted for one-time (income) / expenses, net and non-cash GAAP provision expenses
Financial Highlights
Operating Highlights
Dr. Muharrem Usta, Chairman and Chief Executive Officer of MLP Care, commented:
"We are very pleased to complete 2018 with delivering operational results above expectations and fulfilling promises given to investors during the initial public offering.
"We have focused on the successful ramp up of the two new hospitals opened in 2018 as well as operational improvements to increase patient satisfaction and effective cost management across all our hospitals. Our foreign medical tourism revenues maintained its high growth momentum in 2018. In the last quarter of 2018, we posted net profit thanks to continued growth in EBITDA and appreciation of TL.
"We, as MLP Care, will continue to focus on initiatives for further operational efficiency and to create value for our patients and stakeholders as well as our country."
ENQUIRIES
For financial reports and further information regarding MLP Care, please visit our website at http://investor.mlpcare.com/en/ or you may contact:
Dr. Deniz Can Yücel Strategy and Investor Relations Director T +90 212 227 5555 (Ext: 1148)
|
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.